Friday, March 15, 2013 10:09:49 AM
The bottom line, per the 10K:
Jerry Trepple, as Chairman and CEO took a $0 cash salary for 2011 and 2012, and was paid $30,000 entirely in stock for both years.
Chris Dick, as president and COO, was paid $175,000 in cash for 2011 and 2012, and was paid $25,000 in stock for both years, and $8,400 for an auto allowance (not sure if cash or stock)
Carter Ward, as CFO and Treasurer, was paid $125,000 in cash for 2011 and 2012, and $25,000 i stock.
The directors all recieve $0 cash salaray, and $20,000 retainer all in stock.
Those are ridiculously low salaries for C-level positions, especially for Jerry Trepple, who is working only for the equity upside. Find another CFO who takes $125,000 cash salary - you can't. Chris Dick makes $175,000 in cash but that is paltry compared to other COOs. The directors take no salary, only equity upside.
It's a clear and very strong show of support from managment, no matter how you slice it.
It's all in the 10K, page 59-62. Why is this even a discussion?
Jerry Trepple, as Chairman and CEO took a $0 cash salary for 2011 and 2012, and was paid $30,000 entirely in stock for both years.
Chris Dick, as president and COO, was paid $175,000 in cash for 2011 and 2012, and was paid $25,000 in stock for both years, and $8,400 for an auto allowance (not sure if cash or stock)
Carter Ward, as CFO and Treasurer, was paid $125,000 in cash for 2011 and 2012, and $25,000 i stock.
The directors all recieve $0 cash salaray, and $20,000 retainer all in stock.
Those are ridiculously low salaries for C-level positions, especially for Jerry Trepple, who is working only for the equity upside. Find another CFO who takes $125,000 cash salary - you can't. Chris Dick makes $175,000 in cash but that is paltry compared to other COOs. The directors take no salary, only equity upside.
It's a clear and very strong show of support from managment, no matter how you slice it.
It's all in the 10K, page 59-62. Why is this even a discussion?
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
